Cargando…
Efficacy and Safety of Tranexamic Acid in Emergency Trauma: A Systematic Review and Meta-Analysis
In trauma patients, bleeding can lead to coagulopathy, hemorrhagic shock, and multiorgan failure, and therefore is of fundamental significance in regard to early morbidity. We conducted a meta-analysis to evaluate the efficacy and safety of tranexamic acid (TXA) in civil and military settings and it...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958951/ https://www.ncbi.nlm.nih.gov/pubmed/33802254 http://dx.doi.org/10.3390/jcm10051030 |
_version_ | 1783664891549188096 |
---|---|
author | Al-Jeabory, Mahdi Szarpak, Lukasz Attila, Kecskes Simpson, Michael Smereka, Adam Gasecka, Aleksandra Wieczorek, Wojciech Pruc, Michal Koselak, Maciej Gawel, Wladyslaw Checinski, Igor Jaguszewski, Milosz J. Filipiak, Krzysztof J. |
author_facet | Al-Jeabory, Mahdi Szarpak, Lukasz Attila, Kecskes Simpson, Michael Smereka, Adam Gasecka, Aleksandra Wieczorek, Wojciech Pruc, Michal Koselak, Maciej Gawel, Wladyslaw Checinski, Igor Jaguszewski, Milosz J. Filipiak, Krzysztof J. |
author_sort | Al-Jeabory, Mahdi |
collection | PubMed |
description | In trauma patients, bleeding can lead to coagulopathy, hemorrhagic shock, and multiorgan failure, and therefore is of fundamental significance in regard to early morbidity. We conducted a meta-analysis to evaluate the efficacy and safety of tranexamic acid (TXA) in civil and military settings and its impact on in-hospital mortality (survival to hospital discharge or 30-day survival), intensive care unit and hospital length of stay, incidence of adverse events (myocardial infarct and neurological complications), and volume of blood product transfusion. The systematic review and meta-analysis were conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. A systematic review of the literature using PubMed, Scopus, EMBASE, Web of Science, and the Cochrane Central Register and Controlled Trials (CENTRAL) database was conducted from inception to 10 January 2021. In-hospital mortality was reported in 14 studies and was 15.5% for the TXA group as compared with 16.4% for the non-TXA group (OR = 0.81, 95% CI 0.62–1.06, I(2) = 83%, p = 0.12). In a civilian TXA application, in-hospital mortality in the TXA and non-TXA groups amounted to 15.0% and 17.1%, respectively (OR = 0.69, 95% CI 0.51–0.93, p = 0.02, I(2) = 78%). A subgroup analysis of the randomized control trial (RCT) studies showed a statistically significant reduction in in-hospital mortality in the TXA group (14.3%) as compared with the non-TXA group (15.7%, OR = 0.89, 95% CI 0.83–0.96, p = 0.003, I(2) = 0%). To summarize, TXA used in civilian application reduces in-hospital mortality. Application of TXA is beneficial for severely injured patients who undergoing shock and require massive blood transfusions. Patients who undergo treatment with TXA should be monitored for clinical signs of thromboembolism, since TXA is a standalone risk factor of a thromboembolic event and the D-dimers in traumatic patients are almost always elevated. |
format | Online Article Text |
id | pubmed-7958951 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-79589512021-03-16 Efficacy and Safety of Tranexamic Acid in Emergency Trauma: A Systematic Review and Meta-Analysis Al-Jeabory, Mahdi Szarpak, Lukasz Attila, Kecskes Simpson, Michael Smereka, Adam Gasecka, Aleksandra Wieczorek, Wojciech Pruc, Michal Koselak, Maciej Gawel, Wladyslaw Checinski, Igor Jaguszewski, Milosz J. Filipiak, Krzysztof J. J Clin Med Article In trauma patients, bleeding can lead to coagulopathy, hemorrhagic shock, and multiorgan failure, and therefore is of fundamental significance in regard to early morbidity. We conducted a meta-analysis to evaluate the efficacy and safety of tranexamic acid (TXA) in civil and military settings and its impact on in-hospital mortality (survival to hospital discharge or 30-day survival), intensive care unit and hospital length of stay, incidence of adverse events (myocardial infarct and neurological complications), and volume of blood product transfusion. The systematic review and meta-analysis were conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. A systematic review of the literature using PubMed, Scopus, EMBASE, Web of Science, and the Cochrane Central Register and Controlled Trials (CENTRAL) database was conducted from inception to 10 January 2021. In-hospital mortality was reported in 14 studies and was 15.5% for the TXA group as compared with 16.4% for the non-TXA group (OR = 0.81, 95% CI 0.62–1.06, I(2) = 83%, p = 0.12). In a civilian TXA application, in-hospital mortality in the TXA and non-TXA groups amounted to 15.0% and 17.1%, respectively (OR = 0.69, 95% CI 0.51–0.93, p = 0.02, I(2) = 78%). A subgroup analysis of the randomized control trial (RCT) studies showed a statistically significant reduction in in-hospital mortality in the TXA group (14.3%) as compared with the non-TXA group (15.7%, OR = 0.89, 95% CI 0.83–0.96, p = 0.003, I(2) = 0%). To summarize, TXA used in civilian application reduces in-hospital mortality. Application of TXA is beneficial for severely injured patients who undergoing shock and require massive blood transfusions. Patients who undergo treatment with TXA should be monitored for clinical signs of thromboembolism, since TXA is a standalone risk factor of a thromboembolic event and the D-dimers in traumatic patients are almost always elevated. MDPI 2021-03-03 /pmc/articles/PMC7958951/ /pubmed/33802254 http://dx.doi.org/10.3390/jcm10051030 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Al-Jeabory, Mahdi Szarpak, Lukasz Attila, Kecskes Simpson, Michael Smereka, Adam Gasecka, Aleksandra Wieczorek, Wojciech Pruc, Michal Koselak, Maciej Gawel, Wladyslaw Checinski, Igor Jaguszewski, Milosz J. Filipiak, Krzysztof J. Efficacy and Safety of Tranexamic Acid in Emergency Trauma: A Systematic Review and Meta-Analysis |
title | Efficacy and Safety of Tranexamic Acid in Emergency Trauma: A Systematic Review and Meta-Analysis |
title_full | Efficacy and Safety of Tranexamic Acid in Emergency Trauma: A Systematic Review and Meta-Analysis |
title_fullStr | Efficacy and Safety of Tranexamic Acid in Emergency Trauma: A Systematic Review and Meta-Analysis |
title_full_unstemmed | Efficacy and Safety of Tranexamic Acid in Emergency Trauma: A Systematic Review and Meta-Analysis |
title_short | Efficacy and Safety of Tranexamic Acid in Emergency Trauma: A Systematic Review and Meta-Analysis |
title_sort | efficacy and safety of tranexamic acid in emergency trauma: a systematic review and meta-analysis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958951/ https://www.ncbi.nlm.nih.gov/pubmed/33802254 http://dx.doi.org/10.3390/jcm10051030 |
work_keys_str_mv | AT aljeaborymahdi efficacyandsafetyoftranexamicacidinemergencytraumaasystematicreviewandmetaanalysis AT szarpaklukasz efficacyandsafetyoftranexamicacidinemergencytraumaasystematicreviewandmetaanalysis AT attilakecskes efficacyandsafetyoftranexamicacidinemergencytraumaasystematicreviewandmetaanalysis AT simpsonmichael efficacyandsafetyoftranexamicacidinemergencytraumaasystematicreviewandmetaanalysis AT smerekaadam efficacyandsafetyoftranexamicacidinemergencytraumaasystematicreviewandmetaanalysis AT gaseckaaleksandra efficacyandsafetyoftranexamicacidinemergencytraumaasystematicreviewandmetaanalysis AT wieczorekwojciech efficacyandsafetyoftranexamicacidinemergencytraumaasystematicreviewandmetaanalysis AT prucmichal efficacyandsafetyoftranexamicacidinemergencytraumaasystematicreviewandmetaanalysis AT koselakmaciej efficacyandsafetyoftranexamicacidinemergencytraumaasystematicreviewandmetaanalysis AT gawelwladyslaw efficacyandsafetyoftranexamicacidinemergencytraumaasystematicreviewandmetaanalysis AT checinskiigor efficacyandsafetyoftranexamicacidinemergencytraumaasystematicreviewandmetaanalysis AT jaguszewskimiloszj efficacyandsafetyoftranexamicacidinemergencytraumaasystematicreviewandmetaanalysis AT filipiakkrzysztofj efficacyandsafetyoftranexamicacidinemergencytraumaasystematicreviewandmetaanalysis |